Both in Biotechnology
Anavex Life Sciences vs LENZ Therapeutics
Over the past year AVXL returned −85.2% and LENZ returned −90.0%; their daily moves had a correlation of 0.23.
AVXL −85.2% LENZ −90.0%Growth of $1, one year, split-adjusted
| Metric | AVXL | LENZ |
|---|---|---|
| Price | $1.19 | $3.05 |
| Market cap | $110.3M | $95.8M |
| Today | −8.46% | −12.61% |
| 1 month | −37.0% | −19.5% |
| 6 months | −64.2% | −65.7% |
| Year to date | −66.6% | −80.9% |
| 1 year | −85.2% | −90.0% |
| Revenue growth (YoY) | — | +9.7% |
| Gross margin | — | 94.9% |
| Net margin | — | −581.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 4.5× |
| Net cash | $118.3M | $220.0M |
| Dividend yield | — | — |
| Volatility (60d) | 73.1% | 70.2% |
| Short % of float | 14.0% | 46.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).